Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro

Aim: Immunological checkpoint therapy is considered a powerful method for cancer therapy and acts by re-activating autologous T cells to kill the cancer cell. Myocarditis cases have been reported in cancer patients after immunological therapy; for example, nivolumab treatment is a monoclonal antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Woan Ting, Fang, Yi-Hsien, Beh, Suet Theng, Liu, Yen-Wen, Hsu, Ling-Wei, Yen, Chia-Jui, Liu, Ping-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177768/
https://www.ncbi.nlm.nih.gov/pubmed/32244307
http://dx.doi.org/10.3390/ijms21072399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177768/
https://www.ncbi.nlm.nih.gov/pubmed/32244307
http://dx.doi.org/10.3390/ijms21072399

Ejemplares similares